Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 10/2017

01-10-2017 | Therapies and New Technologies in the Treatment of Type 1 Diabetes (M Pietropaolo, Section Editor)

Management of Type 1 Diabetes in the Hospital Setting

Authors: Carlos E. Mendez, Guillermo E. Umpierrez

Published in: Current Diabetes Reports | Issue 10/2017

Login to get access

Abstract

Purpose of Review

The purpose of this article was to review recent guideline recommendations on glycemic target, glucose monitoring, and therapeutic strategies, while providing practical recommendations for the management of medical and surgical patients with type 1 diabetes (T1D) admitted to critical and non-critical care settings.

Recent Findings

Studies evaluating safety and efficacy of insulin pump therapy, continuous glucose monitoring, electronic glucose management systems, and closed loop systems for the inpatient management of hyperglycemia are described.

Summary

Due to the increased prevalence and life expectancy of patients with type 1 diabetes, a growing number of these patients require hospitalization every year. Inpatient diabetes management is complex and is best provided by a multidisciplinary diabetes team. In the absence of such resource, providers and health care staff must become familiar with the features of this condition to avoid complications such as severe hyperglycemia, ketoacidosis, hypoglycemia, or glycemic variability. We reviewed most recent guidelines and relevant literature in the topic to provide practical recommendations for the inpatient management of patients with T1D.
Literature
1.
Chiang JL, Kirkman MS, Laffel LM, Peters AL. Type 1 diabetes sourcebook authors. Type 1 diabetes through the life span: A position statement of the American Diabetes Association. Diabetes Care. 2014;37(7):2034–54.CrossRefPubMed
2.
3.
Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin N Am. 2010;39(3):481–97.CrossRef
4.
• Sayers A, Thayer D, Harvey JN, Luzio S, Atkinson MD, French R, et al. Evidence for a persistent, major excess in all cause admissions to hospital in children with type-1 diabetes: Results from a large welsh national matched community cohort study. BMJ Open. 2015;(4):5, e005644. This study shows the increased rates of hospitalizations in patients with T1D compared to general population
5.
Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G, EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: A multicentre prospective registration study. Lancet. 2009;373(9680):2027–33.CrossRefPubMed
6.
7.
Icks A, Rosenbauer J, Holl RW, Grabert M, Rathmann W, Giani G, et al. Hospitalization among diabetic children and adolescents and the general population in Germany. German working Group for Pediatric Diabetology. Diabetes Care. 2001;24(3):435–40.CrossRefPubMed
8.
Tomlin AM, Tilyard MW, Dovey SM, Dawson AG. Hospital admissions in diabetic and non-diabetic patients: A case-control study. Diabetes Res Clin Pract. 2006;73(3):260–7.CrossRefPubMed
9.
Donnan PT, Leese GP, Morris AD. Diabetes audit and research in Tayside, Scotland/medicine monitoring unit collaboration. Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Tayside, Scotland: A retrospective cohort study of resource use. Diabetes Care. 2000;23(12):1774–9.CrossRefPubMed
10.
Angus VC, Waugh N. Hospital admission patterns subsequent to diagnosis of type 1 diabetes in children : A systematic review. BMC Health Serv Res. 2007;7:199.CrossRefPubMedPubMedCentral
11.
Robertshaw HJ, Hall GM. Diabetes mellitus: Anaesthetic management. Anaesthesia. 2006;61(12):1187–90.CrossRefPubMed
12.
Umpierrez GE, Kitabchi AE. Diabetic ketoacidosis: Risk factors and management strategies. Treat Endocrinol. 2003;2(2):95–108.CrossRefPubMed
13.
Cryer PE. Hypoglycemia in type 1 diabetes mellitus. Endocrinol Metab Clin N Am. 2010;39(3):641–54.CrossRef
14.
Mendez CE, Umpierrez G. Management of the hospitalized patient with type 1 diabetes mellitus. Hosp Pract (1995). 2013;41(3):89–100.CrossRef
15.
Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38.CrossRefPubMed
16.
Krinsley JS, Egi M, Kiss A, Devendra AN, Schuetz P, Maurer PM, et al. Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: An international multicenter cohort study. Crit Care. 2013;17(2):R37.CrossRefPubMedPubMedCentral
17.
Viens NA, Hug KT, Marchant MH, Cook C, Vail TP, Bolognesi MP. Role of diabetes type in perioperative outcomes after hip and knee arthroplasty in the United States. J Surg Orthop Adv. 2012;21(4):253–60.CrossRefPubMed
18.
Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27(2):553–91.CrossRefPubMed
19.
American Diabetes Association. Standards of medical Care in Diabetes-2017 abridged for primary care providers. Clin Diabetes. 2017;35(1):5–26.CrossRef
20.
Simmons D, Hartnell S, Watts J, Ward C, Davenport K, Gunn E, et al. Effectiveness of a multidisciplinary team approach to the prevention of readmission for acute glycaemic events. Diabet Med. 2015;32(10):1361–7.CrossRefPubMed
21.
Cook CB, Castro JC, Schmidt RE, Gauthier SM, Whitaker MD, Roust LR, et al. Diabetes care in hospitalized noncritically ill patients: More evidence for clinical inertia and negative therapeutic momentum. J Hosp Med. 2007;2(4):203–11.CrossRefPubMed
22.
Cook CB, Kongable GL, Potter DJ, Abad VJ, Leija DE, Anderson M. Inpatient glucose control: A glycemic survey of 126 U.S. hospitals. J Hosp Med. 2009;4(9):E7–E14.CrossRefPubMed
23.
Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL. Insulin pump risks and benefits: A clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of diabetes and the American Diabetes Association diabetes technology working group. Diabetologia. 2015;58(5):862–70.CrossRefPubMed
24.
Duggan EW, Carlson K, Umpierrez GE. Perioperative hyperglycemia management: An update. Anesthesiology. 2017;126(3):547–60.CrossRefPubMed
25.
Bailon RM, Partlow BJ, Miller-Cage V, Boyle ME, Castro JC, Bourgeois PB, et al. Continuous subcutaneous insulin infusion (insulin pump) therapy can be safely used in the hospital in select patients. Endocr Pract. 2009;15(1):24–9.CrossRefPubMed
26.
Cook CB, Boyle ME, Cisar NS, Miller-Cage V, Bourgeois P, Roust LR, et al. Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital setting: Proposed guidelines and outcome measures. Diabetes Educ. 2005;31(6):849–57.CrossRefPubMed
27.
Yogi-Morren D, Lansang MC. Management of patients with type 1 diabetes in the hospital. Curr Diab Rep. 2014;14(2):458.CrossRefPubMed
28.
Fayfman M, Pasquel FJ, Umpierrez GE. Management of Hyperglycemic Crises: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Med Clin North Am. 2017;101(3):587–606.CrossRefPubMed
29.
Umpierrez G, Korytkowski M. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016;12(4):222–32.CrossRefPubMed
30.
Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119–31.CrossRefPubMedPubMedCentral
31.
Smiley D, Rhee M, Peng L, Roediger L, Mulligan P, Satterwhite L, et al. Safety and efficacy of continuous insulin infusion in noncritical care settings. J Hosp Med. 2010;5(4):212–7.CrossRefPubMedPubMedCentral
32.
Juneja R, Foster SA, Whiteman D, Fahrbach JL. The nuts and bolts of subcutaneous insulin therapy in non-critical care hospital settings. Postgrad Med. 2010;122(1):153–62.CrossRefPubMed
33.
Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al. Evaluation and management of adult hypoglycemic disorders: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2009;94(3):709–28.CrossRefPubMed
34.
Cobaugh DJ, Maynard G, Cooper L, Kienle PC, Vigersky R, Childers D, et al. Enhancing insulin-use safety in hospitals: Practical recommendations from an ASHP Foundation expert consensus panel. Am J Health Syst Pharm. 2013;70(16):1404–13.CrossRefPubMed
35.
American Diabetes Association. 14. Diabetes Care in the Hospital. Diabetes Care. 2017;40(Suppl 1):S120–7.CrossRef
36.
Kanji S, Buffie J, Hutton B, Bunting PS, Singh A, McDonald K, et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005;33(12):2778–85.CrossRefPubMed
37.
Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: Confounding issues in setting targets for inpatient management. Diabetes Care. 2007;30(2):403–9.CrossRefPubMed
38.
Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane WV, Vigersky RA, et al. Continuous glucose monitoring: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(10):2968–79.CrossRefPubMed
39.
•• Wallia A, Umpierrez GE, Nasraway SA, Klonoff DC. PRIDE investigators. Round table discussion on inpatient use of continuous glucose monitoring at the international hospital diabetes meeting. J Diabetes Sci Technol. 2016;10(5):1174–81. This article summarizes the potential advantages and disadvantages of using CGM in the hospital setting CrossRefPubMedPubMedCentral
40.
Gottschalk A, Welp HA, Leser L, Lanckohr C, Wempe C, Ellger B. Continuous glucose monitoring in patients undergoing extracorporeal ventricular assist therapy. PLoS One. 2016;11(3):e0148778.CrossRefPubMedPubMedCentral
41.
42.
Kosiborod M, Gottlieb RK, Sekella JA, Peterman D, Grodzinsky A, Kennedy P, et al. Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit. BMJ Open Diabetes Res Care. 2014;2(1):e000037.CrossRefPubMedPubMedCentral
43.
Leelarathna L, English SW, Thabit H, Caldwell K, Allen JM, Kumareswaran K, et al. Accuracy of subcutaneous continuous glucose monitoring in critically ill adults: Improved sensor performance with enhanced calibrations. Diabetes Technol Ther. 2014;16(2):97–101.CrossRefPubMedPubMedCentral
44.
Boom DT, Sechterberger MK, Rijkenberg S, Kreder S, Bosman RJ, Wester JP, et al. Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: A randomized controlled trial. Crit Care. 2014;18(4):453.CrossRefPubMedPubMedCentral
45.
46.
Thomas F, Signal M, Harris DL, Weston PJ, Harding JE, Shaw GM, et al. Continuous glucose monitoring in newborn infants: How do errors in calibration measurements affect detected hypoglycemia? J Diabetes Sci Technol. 2014;8(3):543–50.CrossRefPubMedPubMedCentral
47.
Miller KM, Foster NC, Beck RW, Bergenstal RM, DuBose SN, DiMeglio LA, et al. Current state of type 1 diabetes treatment in the U.S.: Updated data from the T1D exchange clinic registry. Diabetes Care. 2015;38(6):971–8.CrossRefPubMed
48.
Murad MH, Coburn JA, Coto-Yglesias F, Dzyubak S, Hazem A, Lane MA, et al. Glycemic control in non-critically ill hospitalized patients: A systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97(1):49–58.CrossRefPubMed
49.
50.
51.
American Diabetes Association, Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, et al. Nutrition recommendations and interventions for diabetes: A position statement of the American Diabetes Association. Diabetes Care. 2008;31(Suppl 1):S61–78.CrossRef
52.
Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year. J Am Coll Cardiol. 1995;26(1):57–65.CrossRefPubMed
53.
Garber AJ, Moghissi ES, Bransome ED Jr, Clark NG, Clement S, Cobin RH, et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004;10(1):77–82.CrossRefPubMed
54.
Inzucchi SE. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med. 2006;355(18):1903–11.CrossRefPubMed
55.
Nau KC, Lorenzetti RC, Cucuzzella M, Devine T, Kline J. Glycemic control in hospitalized patients not in intensive care: Beyond sliding-scale insulin. Am Fam Physician. 2010;81(9):1130–5.PubMed
56.
Guthrie DW, Guthrie RA, Hinnen D, Childs BP. It's time to abandon the sliding scale. J Fam Pract. 2011;60(5):266–70.PubMed
57.
Page RL, Linnebur SA, Bryant LL, Ruscin JM. Inappropriate prescribing in the hospitalized elderly patient: Defining the problem, evaluation tools, and possible solutions. Clin Interv Aging. 2010;5:75–87.CrossRefPubMedPubMedCentral
58.
Hinzmann R, Schlaeger C, Tran CT. What do we need beyond hemoglobin A1c to get the complete picture of glycemia in people with diabetes? Int J Med Sci. 2012;9(8):665–81.CrossRefPubMedPubMedCentral
59.
Umpierrez GE, Hor T, Smiley D, Temponi A, Umpierrez D, Ceron M, et al. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. J Clin Endocrinol Metab. 2009;94(2):564–9.CrossRefPubMed
60.
• Bellido V, Suarez L, Rodriguez MG, Sanchez C, Dieguez M, Riestra M, et al. Comparison of basal-bolus and premixed insulin regimens in hospitalized patients with type 2 diabetes. Diabetes Care. 2015;38(12):2211–6. This study shows the importance of avoiding premixed insulin in the hospital setting CrossRefPubMedPubMedCentral
61.
Davidson PC, Hebblewhite HR, Steed RD, Bode BW. Analysis of guidelines for basal-bolus insulin dosing: Basal insulin, correction factor, and carbohydrate-to-insulin ratio. Endocr Pract. 2008 Dec;14(9):1095–101.CrossRefPubMed
62.
King AB, Armstrong DU. A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: Bolus dosing. J Diabetes Sci Technol. 2007;1(1):42–6.CrossRefPubMedPubMedCentral
63.
Leonhardi BJ, Boyle ME, Beer KA, Seifert KM, Bailey M, Miller-Cage V, et al. Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital: A review of one institution's experience. J Diabetes Sci Technol. 2008;2(6):948–62.CrossRefPubMedPubMedCentral
64.
Nassar AA, Partlow BJ, Boyle ME, Castro JC, Bourgeois PB, Cook CB. Outpatient-to-inpatient transition of insulin pump therapy: Successes and continuing challenges. J Diabetes Sci Technol. 2010;4(4):863–72.CrossRefPubMedPubMedCentral
65.
Cook CB, Beer KA, Seifert KM, Boyle ME, Mackey PA, Castro JC. Transitioning insulin pump therapy from the outpatient to the inpatient setting: A review of 6 years' experience with 253 cases. J Diabetes Sci Technol. 2012;6(5):995–1002.CrossRefPubMedPubMedCentral
66.
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and Management of Diabetes in Canada. Can J Diabetes. 2013;37(suppl 1):S1–S212.
67.
68.
Munt R, Hutton A. Type 1 diabetes mellitus (T1DM) self management in hospital; is it possible? A literature review. Contemp Nurse. 2012;40(2):179–93.CrossRefPubMed
69.
Jacobi J, Bircher N, Krinsley J, Agus M, Braithwaite SS, Deutschman C, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40(12):3251–76.CrossRefPubMed
70.
Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978–82.CrossRefPubMed
71.
Falciglia M, Freyberg RW, Almenoff PL, D'Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009;37(12):3001–9.CrossRefPubMedPubMedCentral
72.
Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(5):1007–21.CrossRefPubMed
73.
van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359–67.CrossRefPubMed
74.
Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, et al. Intensive insulin therapy and mortality among critically ill patients: A meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821–7.CrossRefPubMed
75.
Wilson M, Weinreb J, Hoo GW. Intensive insulin therapy in critical care: A review of 12 protocols. Diabetes Care. 2007;30(4):1005–11.CrossRefPubMed
76.
American Diabetes Association (ADA). Standards of Medical Care in Diabetes. Diabetes Care 2015; 38(S1-S2).
77.
Newton CA, Smiley D, Bode BW, Kitabchi AE, Davidson PC, Jacobs S, et al. A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. standard column-based algorithms. J Hosp Med. 2010;5(8):432–7.CrossRefPubMedPubMedCentral
78.
Tanenberg RJ, Hardee S, Rothermel C, Drake AJ R. Use of a Computer-Guided Glucose Management System to Improve Glycemic Control and Address National Quality Measures: a 7-Year Retrospective Observational Study at a Tertiary Care Teaching Hospital. Endocr Pract 2016; 14.
79.
Kuntschen F, Galletti PM, Hahn C. Blood glucose control by closed loop insulin delivery during coronary artery bypass surgery. Trans Am Soc Artif Intern Organs. 1981;27:241–5.PubMed
80.
Watson BG, Elliott MJ, Pay DA, Williamson M. Diabetes mellitus and open heart surgery. A simple, practical closed-loop insulin infusion system for blood glucose control. Anaesthesia. 1986;41(3):250–7.CrossRefPubMed
81.
Yatabe T, Nakamura R, Kitagawa H, Munekage M, Hanazaki K. A case of perioperative glucose control by using an artificial pancreas in a patient with glycogen storage disease. J Artif Organs. 2016;19(1):100–3.CrossRefPubMed
82.
•• Namikawa T, Munekage M, Kitagawa H, Yatabe T, Maeda H, Tsukamoto Y, et al. Comparison between a novel and conventional artificial pancreas for perioperative glycemic control using a closed-loop system. J Artif Organs 2016 20. This study shows successful utilization of a closed loop artificial pancreas in the perioperative period
83.
Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Maeda H, Yatabe T, et al. Continuous postoperative blood glucose monitoring and control by artificial pancreas in patients having pancreatic resection: A prospective randomized clinical trial. Arch Surg. 2009;144(10):933–7.CrossRefPubMed
84.
Hanazaki K, Kitagawa H, Yatabe T, Munekage M, Dabanaka K, Takezaki Y, et al. Perioperative intensive insulin therapy using an artificial endocrine pancreas with closed-loop glycemic control system: The effects of no hypoglycemia. Am J Surg. 2014;207(6):935–41.CrossRefPubMed
85.
Maeda H, Okabayashi T, Yatabe T, Yamashita K, Hanazaki K. Perioperative intensive insulin therapy using artificial endocrine pancreas in patients undergoing pancreatectomy. World J Gastroenterol. 2009;15(33):4111–5.CrossRefPubMedPubMedCentral
86.
Yatabe T, Nishigaki A, Kitagawa H, Namikawa T, Hanazaki K, Yokoyama M. Successful treatment of hyperkalaemia with insulin therapy using a closed-loop glycaemic control device. Anaesth Intensive Care. 2016;44(2):294–5.PubMed
87.
Tsukamoto Y, Kinoshita Y, Kitagawa H, Munekage M, Munekage E, Takezaki Y, et al. Evaluation of a novel artificial pancreas: Closed loop glycemic control system with continuous blood glucose monitoring. Artif Organs. 2013;37(4):E67–73.CrossRefPubMed
88.
McDonnell ME, Umpierrez GE. Insulin therapy for the management of hyperglycemia in hospitalized patients. Endocrinol Metab Clin N Am. 2012;41(1):175–201.CrossRef
89.
Hsia E, Seggelke S, Gibbs J, Hawkins RM, Cohlmia E, Rasouli N, et al. Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. J Clin Endocrinol Metab. 2012;97(9):3132–7.CrossRefPubMed
90.
Mucha GT, Merkel S, Thomas W, Bantle JP. Fasting and insulin glargine in individuals with type 1 diabetes. Diabetes Care. 2004;27(5):1209–10.CrossRefPubMed
91.
Tridgell DM, Tridgell AH, Hirsch IB. Inpatient management of adults and children with type 1 diabetes. Endocrinol Metab Clin N Am. 2010;39(3):595–608.CrossRef
92.
Bevier WC, Zisser HC, Jovanovic L, Finan DA, Palerm CC, Seborg DE, et al. Use of continuous glucose monitoring to estimate insulin requirements in patients with type 1 diabetes mellitus during a short course of prednisone. J Diabetes Sci Technol. 2008;2(4):578–83.CrossRefPubMedPubMedCentral
93.
94.
Braithwaite SS. Inpatient insulin therapy. Curr Opin Endocrinol Diabetes Obes. 2008;15(2):159–66.CrossRefPubMed
95.
Via MA, Mechanick JI. Inpatient enteral and parenteral [corrected] nutrition for patients with diabetes. Curr Diab Rep. 2011;11(2):99–105.CrossRefPubMed
96.
Kreymann KG, Berger MM, Deutz NE, Hiesmayr M, Jolliet P, Kazandjiev G, et al. ESPEN guidelines on enteral nutrition: Intensive care. Clin Nutr. 2006;25(2):210–23.CrossRefPubMed
97.
Leon-Sanz M, Garcia-Luna PP, Sanz-Paris A, Gomez-Candela C, Casimiro C, Chamorro J, et al. Glycemic and lipid control in hospitalized type 2 diabetic patients: Evaluation of 2 enteral nutrition formulas low carbohydrate-high monounsaturated fat vs high carbohydrate. JPEN J Parenter Enteral Nutr. 2005;29(1):21–29.
98.
Craig LD, Nicholson S, SilVerstone FA, Kennedy RD. Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in long-term care residents with type 2 diabetes: Results of a pilot trial. Nutrition. 1998;14(6):529–34.CrossRefPubMed
99.
Pasquel FJ, Spiegelman R, McCauley M, Smiley D, Umpierrez D, Johnson R, et al. Hyperglycemia during total parenteral nutrition: An important marker of poor outcome and mortality in hospitalized patients. Diabetes Care. 2010;33(4):739–41.CrossRefPubMed
Metadata
Title
Management of Type 1 Diabetes in the Hospital Setting
Authors
Carlos E. Mendez
Guillermo E. Umpierrez
Publication date
01-10-2017
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 10/2017
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-017-0919-7

Other articles of this Issue 10/2017

Current Diabetes Reports 10/2017 Go to the issue

Microvascular Complications—Retinopathy (JK Sun and PS Silva, Section Editors)

Diabetic Eye Screening: Knowledge and Perspectives from Providers and Patients

Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors)

Cardiovascular and Mortality Risks in Migrant South Asians with Type 2 Diabetes: Are We Winning the Battle?

Diabetes and Pregnancy (M-F Hivert, Section Editor)

Application of One-Step IADPSG Versus Two-Step Diagnostic Criteria for Gestational Diabetes in the Real World: Impact on Health Services, Clinical Care, and Outcomes

Microvascular Complications—Retinopathy (JK Sun and PS Silva, Section Editors)

Animal Models of Diabetic Retinopathy

Microvascular Complications—Retinopathy (JK Sun and PS Silva, Section Editors)

Intraocular Inflammation in Diabetic Populations

Immunology, Transplantation, and Regenerative Medicine (L Piemonti and V Sordi, Section Editors)

Heterogeneity in the Beta-Cell Population: a Guided Search Into Its Significance in Pancreas and in Implants

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits